Michael Cruse

Insider Reports History

Entity
Individual
Location
C/O Reneo Pharmaceuticals, Inc., 12230 El Camino Real, Suite 230, San Diego, CA
Signature
/s/ Jennifer P. Lam, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Cruse:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Reneo Pharmaceuticals, Inc. Chief Operating Officer Common Stock 35.8K $224K $6.28 Dec 9, 2022 Direct
Reneo Pharmaceuticals, Inc. Chief Operating Officer Common Stock 13.7K $86K $6.28 Dec 9, 2022 by Trust
Reneo Pharmaceuticals, Inc. Chief Operating Officer Stock option (right to buy) 125K Dec 9, 2022 Direct

Insider Reports Filed by Michael Cruse

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RPHM Reneo Pharmaceuticals, Inc. Dec 9, 2022 1 $0 4 Dec 13, 2022 Chief Operating Officer
RPHM Reneo Pharmaceuticals, Inc. Sep 1, 2022 1 $25.4K 4 Sep 2, 2022 Chief Operating Officer
RPHM Reneo Pharmaceuticals, Inc. Aug 29, 2022 5 $23.2K 4 Aug 31, 2022 Chief Operating Officer
RPHM Reneo Pharmaceuticals, Inc. Mar 2, 2022 1 $0 4 Mar 4, 2022 Chief Operating Officer
RPHM Reneo Pharmaceuticals, Inc. Dec 10, 2021 2 $0 4 Dec 14, 2021 Senior VP-Corporate Operations
RPHM Reneo Pharmaceuticals, Inc. Aug 25, 2021 1 $18.6K 4 Aug 26, 2021 Senior VP-Corporate Operations